Abstract
Hypoparathyroidism is an orphan disease with ill-defined epidemiology that is subject to geographic variability. We conducted this study to assess the demographics, etiologic distribution, treatment patterns and complication frequency of patients with chronic hypoparathyroidism in Turkey. This is a retrospective, cross-sectional database study, with collaboration of 30 endocrinology centers located in 20 cities across seven geographical regions of Turkey. A total of 830 adults (mean age 49.6 ± 13.5 years; female 81.2%) with hypoparathyroidism (mean duration 9.7 ± 9.0 years) were included in the final analysis. Hypoparathyroidism was predominantly surgery-induced (n = 686, 82.6%). The insulting surgeries was carried out mostly due to benign causes in postsurgical group (SG) (n = 504, 73.5%) while patients in nonsurgical group (NSG) was most frequently classified as idiopathic (n = 103, 71.5%). The treatment was highly dependent on calcium salts (n = 771, 92.9%), calcitriol (n = 786, 94.7%) and to a lower extent cholecalciferol use (n = 635, 76.5%) while the rate of parathyroid hormone (n = 2, 0.2%) use was low. Serum calcium levels were most frequently kept in the normal range (sCa 8.5–10.5 mg/dL, n = 383, 46.1%) which might be higher than desired for this patient group. NSG had a lower mean plasma PTH concentration (6.42 ± 5.53 vs. 9.09 ± 7.08 ng/l, p < 0.0001), higher daily intake of elementary calcium (2038 ± 1214 vs. 1846 ± 1355 mg/day, p = 0.0193) and calcitriol (0.78 ± 0.39 vs. 0.69 ± 0.38 mcg/day, p = 0.0057), a higher rate of chronic renal disease (9.7% vs. 3.6%, p = 0.0017), epilepsy (6.3% vs. 1.6%, p = 0.0009), intracranial calcifications (11.8% vs. 7.3%, p < 0.0001) and cataracts (22.2% vs. 13.7%, p = 0.0096) compared to SG. In conclusion, postsurgical hypoparathyroidism is the dominant etiology of hypoparathyroidism in Turkey while the nonsurgical patients have a higher disease burden with greater need for medications and increased risk of complications than the postsurgical patients.
Similar content being viewed by others
Data Availability
The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
All statistical analyses were performed using GraphPad Prism version 9.0.0 for Mac OS.
References
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Juppner H, D’Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317–2337
Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, Peacock M, Raffaelli M, Silva BC, Thakker RV, Vokes T, Bouillon R (2016) Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 101:2300–2312
Clarke BL (2018) Epidemiology and complications of hypoparathyroidism. Endocrinol Metab Clin N Am 47:771–782
Bilezikian JP (2020) Hypoparathyroidism. J Clin Endocrinol Metab 105:1722–1736
Vadiveloo T, Donnan PT, Leese GP (2018) A population-based study of the epidemiology of chronic hypoparathyroidism. J Bone Miner Res 33:478–485
Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML, Marcocci C, Rejnmark L, Rizzoli R, Shrayyef MZ, Thakker R, Yildiz BO, Clarke B (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol 180:P1–P22
Shoback D (2008) Clinical practice. Hypoparathyroidism. N Engl J Med 359:391–403
Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker R, Sitges-Serra A, Cetani F, Marcocci C (2019) Management of endocrine disease: unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol 181:P1–P19
Abate EG, Clarke BL (2016) Review of hypoparathyroidism. Front Endocrinol (Lausanne) 7:172
Hadker N, Egan J, Sanders J, Lagast H, Clarke BL (2014) Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr Pract 20:671–679
Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP (2019) Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf) 90:285–292
Astor MC, Lovas K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebo BG, Svartberg J, Husebye ES (2016) Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab 101:3045–3053
Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97:4507–4514
Gronskaia S, Melnichenko G, Rozhinskaya L, Grebennikova T, Mamedova E, Pigarova E, Przhialkovskaya E, Dzeranova L, Dedov I, Fadeyev V, Brandi ML, Belaya Z (2020) A registry for patients with chronic hypoparathyroidism in Russian adults. Endocr Connect 9:627–636
Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S, Betterle C, Bondanelli M, Boscaro M, Camozzi V, Centaro GM, Cetani F, Chiodini I, Ciampolillo A, Colao A, Corbetta S, De Feo ML, Uberti ED, Faggiano A, Fornari R, Gaspari AL, Giorgino F, Giuliani V, Iacobone M, Innaro N, Lamacchia O, Lenzi A, Mantovani G, Marcocci C, Masi L, Migliaccio S, Palmieri S, Pasquali R, Perigli G, Piccini V, Romagnoli E, Ruggeri RM, Rulli F, Sama MT, Tomaino G, Trimarchi F, Zatelli MC, Brandi ML (2018) HypoparaNet: a database of chronic hypoparathyroidism based on expert medical-surgical centers in Italy. Calcif Tissue Int 103:151–163
Yagmur Y, Akbulut S, Sakarya H, Sogutcu N, Gumus S (2018) Assessment of the relationship between clinical and histopathological features in cases of thyroidectomy. Ann Ital Chir 89:199–205
Tezelman S, Borucu I, Senyurek Giles Y, Tunca F, Terzioglu T (2009) The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg 33:400–405
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30:1738–1744
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28:2277–2285
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism—risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29:2504–2510
Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155–3159
Cipriani C, Minisola S, Bilezikian JP, Diacinti D, Colangelo L, Piazzolla V, Angelozzi M, Nieddu L, Pepe J, Diacinti D (2021) Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism. J Clin Endocrinol Metab 106:1303–1311
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Ceyla Konca Degertekin, Dilek Gogas Yavuz, Zafer Pekkolay, Emre Saygili, Kader Ugur, Arzu Or Koca, Mustafa Unubol, Omercan Topaloglu, Berna Imge Aydogan, Nilufer Ozdemir Kutbay, Zeliha Hekimsoy, Nusret Yilmaz, Mustafa Kemal Balci, Seher Tanrikulu, Yasemin Aydogan Unsal, Canan Ersoy, Tulay Omma, Muge Keskin, Muhittin Yalcin, Ilhan Yetkin, Hikmet Soylu, Melia Karakose, Merve Yilmaz, Ersen Karakilic, Hamide Piskinpasa, Adnan Batman, Gulhan Akbaba, Gulsah Elbuken, Cigdem Tura Bahadir, Faruk Kilinc, Muhammet Cuneyt Bilginer, Ozlem Turhan Iyidir, Zeynep Canturk, Banu Aktas Yilmaz, Zeynel Abidin Sayiner, Mustafa Eroglu declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethical Approval
The study protocol was approved by the local ethics committee of Marmara University School of Medicine (09.2018.756). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Human and Animal Rights and Informed Consent
This retrospective chart review study involving human participants was in accordance with the ethical standarts of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standarts. The local ethics committee of Marmara University School of Medicine approved this study (09.2018.756).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Konca Degertekin, C., Gogas Yavuz, D., Pekkolay, Z. et al. Identifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Study. Calcif Tissue Int 110, 204–214 (2022). https://doi.org/10.1007/s00223-021-00908-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-021-00908-2